0001753926-21-000252.txt : 20210713 0001753926-21-000252.hdr.sgml : 20210713 20210713164514 ACCESSION NUMBER: 0001753926-21-000252 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210713 DATE AS OF CHANGE: 20210713 EFFECTIVENESS DATE: 20210713 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Predictive Health Diagnostics Co. CENTRAL INDEX KEY: 0001694554 IRS NUMBER: 814578409 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-406096 FILM NUMBER: 211088377 BUSINESS ADDRESS: STREET 1: 510 VIA DELFIN CITY: SAN CLEMENTE STATE: CA ZIP: 92672 BUSINESS PHONE: 9495473140 MAIL ADDRESS: STREET 1: 510 VIA DELFIN CITY: SAN CLEMENTE STATE: CA ZIP: 92672 D 1 primary_doc.xml X0708 D LIVE 0001694554 Predictive Health Diagnostics Co. 13885 ALTON PARKWAY, SUITE B IRVINE CA CALIFORNIA 92618 866-299-8998 DELAWARE None None Corporation true 2016 Matthew Nunez 13885 ALTON PARKWAY, SUITE B IRVINE CA CALIFORNIA 92618 Executive Officer Director Douglas Harrington 13885 ALTON PARKWAY, SUITE B IRVINE CA CALIFORNIA 92618 Director Estrella Harrington 13885 ALTON PARKWAY, SUITE B IRVINE CA CALIFORNIA 92618 Director Suzy Lu 13885 ALTON PARKWAY, SUITE B IRVINE CA CALIFORNIA 92618 Director Munira al Delemi 13885 ALTON PARKWAY, SUITE B IRVINE CA CALIFORNIA 92618 Director Yonghong Wu 13885 ALTON PARKWAY, SUITE B IRVINE CA CALIFORNIA 92618 Director Other Health Care Decline to Disclose 06b false 2021-02-25 false true false 10000 Boustead Securities 141391 None None 6 VENTURE, SUITE 395 IRVINE CA CALIFORNIA 92618 All States false 8307000 8307000 0 false 66 430990 0 Boustead Securities were issued warrants to purchase up to 172,396 shares of Series A Preferred Stock of the Company with an exercise price of $2.50 per share in connection with its placement agent services in this offering. 0 false Predictive Health Diagnostics Co. /s/ Matthew Nunez Matthew Nunez Chief Executive Officer 2021-07-12